GlassScriptPhysician profile
Christopher M Foret
NPI 1245251602
$2,796.36
in general payments reported to CMS, 2019-2025
18 companies · $65.34 in 2025
The $65.34 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,363 · 2020: $45.36 · 2022: $97.91 · 2023: $74.94 · 2024: $150 · 2025: $65.34.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $291.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $290.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $2,250.00 | 2019 | |
| Supernus Pharmaceuticals, INC. | $67.49 | 2019-2020 | |
| Ultragenyx Pharmaceutical INC. | $66.66 | 2022 | |
| Allergan, INC. | $61.49 | 2019 | |
| Pfizer INC. | $55.35 | 2022-2025 | |
| Exact Sciences Corporation | $52.46 | 2023-2024 | Cologuard Collection Kit |
| Medtronic, INC. | $32.16 | 2025 | Protege Rx |
| Glaxosmithkline, LLC. | $30.27 | 2020-2022 | |
| Organon LLC | $27.60 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $20.96 | 2023 | Eliquis |
| Dexcom, INC. | $18.47 | 2023 | Dexcom G6 Transmitter |
| Kestra Medical Technology Services, INC. | $18.24 | 2024 | Assure Wcd |
| Amgen INC. | $17.90 | 2024 | Repatha, Otezla |
| Bayer Healthcare Pharmaceuticals INC. | $17.46 | 2023 | |
| Abbott Laboratories | $16.26 | 2024 | Freestyle Libre |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $15.80 | 2025 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.10 | 2024 | Jardiance |
| Sanofi-Aventis U.S. LLC | $12.69 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Foret listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.